The localization of epithelial membrane antigen (EMA) and carcinoembryonic antigen (CEA) in exfoliated cells from voided urine was examined to clarify whether immunostaining for these markers is more useful than conventional cytology for diagnosis of patients with transitional cell carcinoma of the bladder. Both EMA and CEA were present more frequently in specimens from higher-grade and higher-stage tumors than lower-grade and lower-stage tumors. Cells positive for one or both of these markers were also found in specimens from cancer patients with only suspicious results by conventional cytology. In grade 1 tumors, the positive rates were 50% for EMA staining and 40% for CEA staining compared with 10% for conventional cytology. In 12 patients with cystitis, results for EMA staining and conventional cytology were all negative, whereas CEA staining proved positive in 6 patients (50%). None of 10 normal subjects with conventional cytology had positive results for EMA or CEA staining. These findings indicate that immunocytochemistry for EMA is a more useful adjunctive method than CEA staining or conventional cytology for detection of tumor cells, especially in cases of low-grade bladder cancer.

Keywords:
Epithelial membrane antigen, Carcinoembryonic antigen, Immunocytochemistry
This content is only available via PDF.
© 1994 S. Karger AG, Basel
1994
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.